Identification of Five Ferroptosis-Related LncRNAs as Novel Prognosis and Diagnosis Signatures for Renal Cancer

Background: Ferroptosis is a novel regulated cell death that is characterized by iron-dependent oxidative damage. Renal cancer is the second most common cancer of the urinary system, which is highly correlated with iron metabolism. The aim of our present study was to identify suitable ferroptosis-re...

Full description

Bibliographic Details
Main Authors: Xiangjun Shu, Zaiqi Zhang, Zhi-Yong Yao, Xiao-Liang Xing
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2021.763697/full
_version_ 1818988210114527232
author Xiangjun Shu
Xiangjun Shu
Zaiqi Zhang
Zhi-Yong Yao
Xiao-Liang Xing
Xiao-Liang Xing
author_facet Xiangjun Shu
Xiangjun Shu
Zaiqi Zhang
Zhi-Yong Yao
Xiao-Liang Xing
Xiao-Liang Xing
author_sort Xiangjun Shu
collection DOAJ
description Background: Ferroptosis is a novel regulated cell death that is characterized by iron-dependent oxidative damage. Renal cancer is the second most common cancer of the urinary system, which is highly correlated with iron metabolism. The aim of our present study was to identify suitable ferroptosis-related prognosis signatures for renal cancer.Methods: We downloaded the RNA-seq count data of renal cancer from The Cancer Genome Atlas database and used the DESeq2, Survival, and Cox regression analyses to screen the prognosis signatures.Results: We identified 5 ferroptosis-related differentially expressed lncRNAs (FR-DELs) (DOCK8-AS1, SNHG17, RUSC1-AS1, LINC02609, and LUCAT1) to be independently correlated with the overall survival (OS) of patients with renal cancer. The risk assessment model and diagnosis model constructed by those 5 FR-DELs could well predict the outcome and the diagnosis of renal cancer.Conclusion: Our present study not only suggested those 5 FR-DELs could be used as prognosis and diagnosis signatures for renal cancer but also provided strategies for other cancers in the screening of ferroptosis-related biomarkers.
first_indexed 2024-12-20T19:18:57Z
format Article
id doaj.art-06341c888165440b839368fa4a077183
institution Directory Open Access Journal
issn 2296-889X
language English
last_indexed 2024-12-20T19:18:57Z
publishDate 2022-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Biosciences
spelling doaj.art-06341c888165440b839368fa4a0771832022-12-21T19:29:03ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2022-01-01810.3389/fmolb.2021.763697763697Identification of Five Ferroptosis-Related LncRNAs as Novel Prognosis and Diagnosis Signatures for Renal CancerXiangjun Shu0Xiangjun Shu1Zaiqi Zhang2Zhi-Yong Yao3Xiao-Liang Xing4Xiao-Liang Xing5School of Public Health and Laboratory Medicine, Hunan University of Medicine, Huaihua, ChinaThe First Affiliated Hospital, Hunan University of Medicine, Huaihua, ChinaThe First Affiliated Hospital, Hunan University of Medicine, Huaihua, ChinaThe First Affiliated Hospital, Hunan University of Medicine, Huaihua, ChinaSchool of Public Health and Laboratory Medicine, Hunan University of Medicine, Huaihua, ChinaThe First Affiliated Hospital, Hunan University of Medicine, Huaihua, ChinaBackground: Ferroptosis is a novel regulated cell death that is characterized by iron-dependent oxidative damage. Renal cancer is the second most common cancer of the urinary system, which is highly correlated with iron metabolism. The aim of our present study was to identify suitable ferroptosis-related prognosis signatures for renal cancer.Methods: We downloaded the RNA-seq count data of renal cancer from The Cancer Genome Atlas database and used the DESeq2, Survival, and Cox regression analyses to screen the prognosis signatures.Results: We identified 5 ferroptosis-related differentially expressed lncRNAs (FR-DELs) (DOCK8-AS1, SNHG17, RUSC1-AS1, LINC02609, and LUCAT1) to be independently correlated with the overall survival (OS) of patients with renal cancer. The risk assessment model and diagnosis model constructed by those 5 FR-DELs could well predict the outcome and the diagnosis of renal cancer.Conclusion: Our present study not only suggested those 5 FR-DELs could be used as prognosis and diagnosis signatures for renal cancer but also provided strategies for other cancers in the screening of ferroptosis-related biomarkers.https://www.frontiersin.org/articles/10.3389/fmolb.2021.763697/fullrenal cancerferroptosisdifferentially expressed lncRNAsprognosisdiagnosis
spellingShingle Xiangjun Shu
Xiangjun Shu
Zaiqi Zhang
Zhi-Yong Yao
Xiao-Liang Xing
Xiao-Liang Xing
Identification of Five Ferroptosis-Related LncRNAs as Novel Prognosis and Diagnosis Signatures for Renal Cancer
Frontiers in Molecular Biosciences
renal cancer
ferroptosis
differentially expressed lncRNAs
prognosis
diagnosis
title Identification of Five Ferroptosis-Related LncRNAs as Novel Prognosis and Diagnosis Signatures for Renal Cancer
title_full Identification of Five Ferroptosis-Related LncRNAs as Novel Prognosis and Diagnosis Signatures for Renal Cancer
title_fullStr Identification of Five Ferroptosis-Related LncRNAs as Novel Prognosis and Diagnosis Signatures for Renal Cancer
title_full_unstemmed Identification of Five Ferroptosis-Related LncRNAs as Novel Prognosis and Diagnosis Signatures for Renal Cancer
title_short Identification of Five Ferroptosis-Related LncRNAs as Novel Prognosis and Diagnosis Signatures for Renal Cancer
title_sort identification of five ferroptosis related lncrnas as novel prognosis and diagnosis signatures for renal cancer
topic renal cancer
ferroptosis
differentially expressed lncRNAs
prognosis
diagnosis
url https://www.frontiersin.org/articles/10.3389/fmolb.2021.763697/full
work_keys_str_mv AT xiangjunshu identificationoffiveferroptosisrelatedlncrnasasnovelprognosisanddiagnosissignaturesforrenalcancer
AT xiangjunshu identificationoffiveferroptosisrelatedlncrnasasnovelprognosisanddiagnosissignaturesforrenalcancer
AT zaiqizhang identificationoffiveferroptosisrelatedlncrnasasnovelprognosisanddiagnosissignaturesforrenalcancer
AT zhiyongyao identificationoffiveferroptosisrelatedlncrnasasnovelprognosisanddiagnosissignaturesforrenalcancer
AT xiaoliangxing identificationoffiveferroptosisrelatedlncrnasasnovelprognosisanddiagnosissignaturesforrenalcancer
AT xiaoliangxing identificationoffiveferroptosisrelatedlncrnasasnovelprognosisanddiagnosissignaturesforrenalcancer